ABP

Abpro Holdings, Inc Common Stock
ABP
Market cap $67.4M

1.30 USD

-0.05

3.70%

At close Jan 17, 4:00 PM EST

Pre-market

1.30

+0.00

0.00%

1 day

-3.70%

5 days

-7.14%

1 month

5.69%

3 months

-64.96%

6 months

-64.96%

Year to date

-17.20%

1 year

-64.96%

5 years

-64.96%

10 years

-64.96%

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

Healthcare Biological Products, Except Diagnostic Substances

–

Funds holding %

of 6,823 funds

–

Analysts bullish %